SEC 13F Intelligence

Endurant Capital Management LP / TEVA

Endurant Capital Management LP’s Teva Pharmaceutical Inds Ltd Position

Does Endurant Capital Management LP own Teva Pharmaceutical Inds Ltd (TEVA)? Not currently — the last reported position was 762.3K shares worth $7M in Q1 2023; the fund’s latest 13F (Q1 2024) no longer reports it.

Position Value
$7M
Q1 2023
Shares
762.3K
% of Portfolio
+3.47%
Quarters Held
4
position exited

Position History TEVA

Reported value by quarter
Q4 ’18: $1MQ4 ’18Q2 ’22: $3MQ2 ’22Q3 ’22: $1MQ3 ’22Q1 ’23: $7MQ1 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2023762.3K$7M+3.47%
Q3 2022179.2K$1M+0.47%
Q2 2022459.8K$3M+1.21%
Q4 201873.9K$1M+0.60%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Endurant Capital Management LP’s full portfolio or all institutional holders of TEVA.